Long Progression-free-survival Pancreatic Carcinosarcoma Under Gemcitabine-nabpaclitaxel First Line Chemotherapy


Long Progression-free-survival Pancreatic Carcinosarcoma Under Gemcitabine-nabpaclitaxel First Line Chemotherapy


Miguel Borregón Rivilla, Katherin Martínez-Barroso, Alba Ramos Garrido, Irene Ramos Reguera, Beatriz Berzal Hernández, Manuel Alejandro Mazariegos Rubi, Cristina Gómez Palmero, Margarita Díez de los Ríos, Irene Otero Blas, Ana Belén Rupérez Blanco, Javier Medina Martínez, Lourdes Fernández Franco, Ana María González Ageitos, Luis López Gómez

Medical Oncology Service, Virgen de la Salud Hospital, Toledo, Spain


Carcinosarcoma of the pancreas is a rare entity with short case series reported in the literature. Diagnosis is established by immunohistochemical examination including both carcinomatous and sarcomatous components. Prognosis is usually limited to 6-9 months life expectancy. Standard chemotherapy regimen is not well defined.
We present a case of pancreatic carcinosarcoma with long-time progression-free-survival under first line chemotherapy treatment with gemcitabine-nabpaclitaxel combination. Tumor histopathological and clinical characteristics are reviewed.


Keywords: Carcinosarcoma; Pancreas; Gemcitabine-Nabpaclitaxel; Cytokeratin; Vimentin


Free Full-text PDF


How to cite this article:

Miguel Borregón Rivilla, Katherin Martínez-Barroso, Alba Ramos Garrido, Irene Ramos Reguera, Beatriz Berzal Hernández, Manuel Alejandro Mazariegos Rubi, Cristina Gómez Palmero, Margarita Díez de los Ríos, Irene Otero Blas, Ana Belén Rupérez Blanco, Javier Medina Martínez, Lourdes Fernández Franco, Ana María González Ageitos, Luis López Gómez. Long Progression-free-survival Pancreatic Carcinosarcoma Under Gemcitabine-nabpaclitaxel First Line Chemotherapy. International Journal of Case Reports, 2020 4:186. DOI: 10.28933/ijcr-2020-11-1605


References:

1. Darvishian F, Sullivan J, Teichberg S, Basham K. Carcinosarcoma of the pancreas. Arch Pathol Lab Med 2002; 126:1114-17.
2. Millis JM, Chang B, Zinner MJ, Barsky SH. Ma-lignant mixed tumour (carcinosarcoma) of the pancreas: a case report supporting organ-induced differentiation of malignancy. Surgery 1994; 115:132-7.
3. Bloomston M, Chanona-Vilchis J, Ellison EC, Ramirez NC, Frankel WL. Carcinosarcoma of the pancreas arising in a mucinous cystic neoplasm. Am Surg 2006; 72: 351-355.
4. Nakano T, Sonobe H, Usui T, et al. Immuno-histochemistry and k-ras sequence of pancreatic carcinosarcoma. Pathol Int 2008; 58: 672- 677.
5. Watanabe M, Miura H, Inoue H, et al. Mixed os-teoclastic/pleomorphic-type giant cell tumor of the pancreas with ductal adenocarcinoma: Histo-chemical and immunohistochemical study with review of the literature. Pancreas 1997; 15: 201-208
6. Wenig BM, Albores-Saavedra J, Buetow PC, Heffess CS. Pancreatic mucinous cystic neo-plasm with sarcomatous stroma: A report of three cases. Am J Surg Pathol 1997; 21: 70-80.
7. Bosman T, Carneiro F, Hruban RH, Theise N.D. World Health Organization Classification of Tu-mours the Digestive system. 4th Edition. IARC Press Lyon. 2010.
8. Abeln EC, Smit VT, Wessels JW, de Leeuw WJ, Cornelisse CJ, Fleuren GJ. Molecular genetic ev-idence for the conversion hypothesis of the origin of malignant mixed mullerian tumours. J Pathol 1997; 183: 424-431.
9. Wada H, Enomoto T, Fujita M, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997; 57: 5379-5385.
10. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group patho-logic study of 203 cases. Int J Gynecol Pathol 1990; 9:1-19.
11. Singh R. Review literature on uterine carcinosar-coma. J Cancer Res Ther. 2014;10:461–468.
12. Huszar M, Herczeg E, Lieberman Y, Geiger B. Distinctive immunofluorescent labeling of epithe-lial and mesenchymal elements of carcinosar-coma with antibodies specific for different in-termediate filaments. Hum Pathol 1984; 15:532-8.
13. Hyun-Soo Kim, Sun Hyung Joo, Dal Mo Yang, Sang Hyun Lee, Sung Ho Choi, Sung-Jig Lim. Carcinosarcoma of the Pancreas: A Unique Case with Emphasis on Metaplastic Transformation and the Presence of Undifferentiated Pleo-morphic High-Grade Sarcoma. J Gastrointestin Liver Dis 2011; 20(2):197-200.
14. Yamazaki K. A unique pancreatic ductal adeno-carcinoma with carcinosarcomatous histology, immunohistochemical distribution of hCG-beta, and the elevation of serum alpha-feto-protein. J Submicrosc Cytol Pathol 2003; 35:343-9.
15. Van den Berg W, Tascilar M, Offerhaus GJ, et al. Pancreatic mucinous cystic neoplasms with sar-comatous stroma: molecular evidence for mon-oclonal origin with subsequent divergence of the epithelial and sarcomatous components. Mod Pathol 2000;13:86– 91.
16. Somarelli JA, Boss MK, Epstein JI, et al. Carci-nosarcomas: tumors in transition? Histol Histo-pathol. 2015;30:673–687.
17. Barkatullah SA, Deziel DJ, Jakate SM, Kluskens L, Komanduri S. Pancreatic carcinosarcoma with unique triphasic histological pattern. Pancreas 2005; 31: 291-292 [PMID: 16163064 DOI: 10.1097/01.mpa.0000178283.96276.8a].
18. Okamura J, Sekine S, Nara S, Ojima H, Shimada K, Kanai Y, Hiraoka N. Intraducta carcinosar-coma with a heterologous mesenchymal compo-nent originating in intraductal papillarymucinous carcinoma (IPMC) of the pancreas with both car-cinoma and osteosarcoma cells arising from IPMC cells. J Clin Pathol 2010; 63: 266-269 [PMID: 20203229 DOI: 10.1136/ jcp.2009.071613].
19. Zhe Jia, Ke Zhang, RongHai Huang, XinGang Zhou, Li Jiang; Pancreatic carcinosarcoma with rare long-term survival, Case report and review of the literature; Medicine (2017) 96:4(e5966).
20. Hong-Yuan Shi, Jing Xie, Fei Miao; Pancreatic carcinosarcoma: First literature report on com-puted tomography imaging; World J Gastroen-terol 2015 January 28; 21(4): 1357-1361.
21. Sasha A. Still, Carlos R. Becerra, Stacia E. Clement-Kruzel, and Keith M. Cavaness; Locally advanced carcinosarcoma of the pancreas; PROC (BAYL UNIV MED CENT) 2018;31(2):210–212.
22. Zhu WY, Liu TG, Zhu H. Long-term recurrence-free survival in a patient with pancreatic carcino-sarcoma: a case report with a literature review. Med Oncol 2012; 29: 140-143 [PMID: 21264541 DOI: 10.1007/s12032-010-9804-9].
23. Oymaci E, Argon A, Coskun A, et al. Pancreatic carcinosarcoma: case report of a rare type of pancreatic neoplasia. JOP 2013;14: 212–5.
24. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients un-dergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297:267-7.


Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).



This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.